ERBB2 and neoplasm: The goal was also to establish the correlation of the Sdc1 expression with clinical and tumor parameters and the expression of the estrogen/progesterone receptors (ERs/PRs) and HER2/neu oncoprotein in both types of primary tumors and to determine the possibility of defining and isolating the group of tumors with more aggressive biological behavior prone to metastasis.